We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Post-Teva Expert Disclosure Trends In 2 Patent-Rich Districts

Law360 (December 10, 2018, 11:28 AM EST) -- Since the U.S. Supreme Court’s 2015 Teva Pharmaceuticals USA Inc. v. Sandoz Inc. decision changed the standard of review for extrinsic evidence in patent infringement cases, expert declarations and testimony during...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.